Should Dying Patients Have Access to Experimental Drugs?
Friday, December 15, 2006
Dr. Jerome Groopman tells us about the FDA's dramatic new proposal to make experimental drugs available to seriously ill patients—the subject of his article “The Right to a Trial” in the New Yorker.

Leave a Comment
Register for your own account so you can vote on comments, save your favorites, and more. Learn more.
Please stay on topic, be civil, and be brief.
Email addresses are never displayed, but they are required to confirm your comments. Names are displayed with all comments. We reserve the right to edit any comments posted on this site. Please read the Comment Guidelines before posting. By leaving a comment, you agree to New York Public Radio's Privacy Policy and Terms Of Use.